← All trials
NCT00878553
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2010
- Primary completion
- Dec 1, 2010
- Completion date
- Aug 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 67
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Somnus Therapeutics, Inc.Lead sponsor
- Neurotrials Inc.Overall official - principal investigator
- Broward Research GroupOverall official - principal investigator
- Emsellem MD PCOverall official - principal investigator
- Sleep Disorders Center of GeorgiaOverall official - principal investigator
- Vince & AssociatesOverall official - principal investigator
- INC ResearchCollaborator
- ClinilabsOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.